Moreover, in an autopsy series of six cancer patients treated with CTLA-4 blockade, one had clinical and pathologic evidence of hypophysitis, while a second one had mild lymphocytic infiltration in the pituitary gland without clinical signs of hypophysitis [17]. This evidence concerns the gene CTLA4 and hypophysitis.